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Fetal growth restriction (FGR) causes a wide variety of defects in the neonate which
can lead to increased risk of heart disease, diabetes, anxiety and other disorders later
in life. However, the effect of FGR on the immune system, is poorly understood. We
used a well-characterized mouse model of FGR in which placental Igf-2 production
is lost due to deletion of the placental specific Igf-2 P0 promotor. The thymi in such
animals were reduced in mass with a !70% reduction in cellularity. We used single cell
RNA sequencing (Drop-Seq) to analyze 7,264 thymus cells collected at postnatal day
6. We identified considerable heterogeneity among the Cd8/Cd4 double positive cells
with one subcluster showing marked upregulation of transcripts encoding a sub-set of
proteins that contribute to the surface of the ribosome. The cells from the FGR animals
were underrepresented in this cluster. Furthermore, the distribution of cells from the FGR
animals was skewed with a higher proportion of immature double negative cells and
fewer mature T-cells. Cell cycle regulator transcripts also varied across clusters. The
T-cell deficit in FGR mice persisted into adulthood, even when body and organ weights
approached normal levels due to catch-up growth. This finding complements the altered
immunity found in growth restricted human infants. This reduction in T-cellularity may
have implications for adult immunity, adding to the list of adult conditions in which the in
utero environment is a contributory factor.
Keywords: Drop-Seq, fetal growth restriction, T-cell, thymus, single-cell, developmental programming
INTRODUCTION
Fetal growth restriction (FGR) is a serious condition a!ecting between 3 and 7% of infants in
developed nations (1) but can be higher than 40% in low-income nations (2). The growth restricted
infants su!er from an increased risk of a wide variety of acute complications, including necrotizing
enterocolitis, perinatal asphyxia, hypothermia, hypoglycemia, immunodeficiency, and death (3).
FGR is commonly attributed to insu"cient fetal nutrients. This may be because either the mother is
malnourished, as in the prototypical case of the DutchHungerWinter (4), or because the placenta is
dysfunctional, leading to poor nutrient transport to the fetus (5). Severely growth restricted infants
exhibit asymmetric growth wherein resources are reallocated to the fetal brain at the cost of the rest
of the body (6), so called “brain sparing.” The infants undergo “catch-up growth” for years, although
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some may remain small for life (7). Unfortunately, this rapid
growth often fails to overcome the complications of intrauterine
restriction, as a wide variety of morbidities including diabetes (8),
polycystic ovary syndrome (9), or perturbed mental health (10)
have been linked to FGR or catch-up growth (11). Together, these
support the “Developmental Origins of Adult Disease” paradigm,
wherein adverse factors during critical periods of fetal growth
irreversibly impact development (11, 12). To overcome these
e!ects, a clear understanding of the mechanism for each of these
sequelae is necessary (13).
Several animal models have been developed for the study of
adult diseases originating in the uterus. Most of these involve
restricting certain nutritional components, such as protein (14)
or oxygen (15) in pregnant dams. However, this does not
distinguish betweenmaternal placental e!ects. The Igf-2P0 model
overcomes this through knock-out of placenta-specific insulin-
like growth factor 2. There are four Igf-2 isoforms which result
from the use of di!erent promoters although they ultimately
generate the same protein. The P0 promoter is specific to
the placenta. This gene is paternally imprinted, allowing for
generation of both wildtype and a!ected o!spring within the
same litter. Importantly, all o!spring develop in a wildtype
dam, preventing maternal variables from a!ecting development.
This targeted knock-out reduces placental growth and therefore
the nutrient transport to the fetus, resulting in a brain-sparing
phenotype reminiscent of human FGR (16). Early hypocalcemia
in the fetuses of these mice (17) mimics the hypocalcemia found
in human neonates (18). These mice have been shown to develop
anxiety later in life (19), which recapitulates known long-term
e!ects of FGR on mental health (20).
While long-term e!ects are a subject of much interest, most
acute FGR complications are simply attributed to a lack of tissue
mass and developmental delay: for example, a smaller and less
mature kidney (21), pancreas (22), or bowel (23) will simply not
function as well. Adaptive immunity is mediated by T-cells which
develop in the thymus. However, while the thymus is a short-lived
organ which involutes shortly after birth it continues to function
well into adult life (24). Deleterious e!ects on this transient organ
could, therefore, have a significant and irreversible impact on
immunity in adult life. Initially, infants with FGR have acutely
smaller thymi and altered CD4/CD8 ratios of peripheral T cells
(25). Later in life, FGR is associated with abnormal responses
to vaccines and higher rates of death due to infection (26).
For example, indirect evidence comes from a study showing
that young adults born in the annual “hungry season” in rural
Gambia—and therefore likely to be born with FGR—have a 10-
fold higher risk of premature death, largely due to infection
(27).
At a cellular level, broad definitions classify cells based
on discrete cell-surface markers. In T-cell development,
lymphoid progenitors travel from the bone marrow through the
bloodstream to arrive at the thymus where NOTCH signaling
directs them toward the T-cell lineage (28). These cells divide
and di!erentiate through four stages of DN (double negative,
referring to lack of either CD4 or CD8 T-cell surface markers)
whilst undergoing Tcr! rearrangements in the thymic cortex.
With the correct set of signals, a minority of the cells become
!" T cells. The rest gain CD8 and then CD4 surface makers
(DP, double-positive) at which point Tcr" rearrangements take
place. The rearrangements provide the diverse T-cell receptor
repertoire necessary for antigen recognition. The cell is then
activated by either MHC Class I or Class II molecules presenting
self-antigens. Strong a"nity for either MHC Class I or Class II
leads to apoptosis to prevent auto-immune disease. Weak a"nity
to Class I or II leads to di!erentiation into either CD8+ cytotoxic
T cells or CD4+ T helper cells, respectively. Intermediate a"nity
to Class II molecules leads to di!erentiation into a T-regulatory
cell. Errors anywhere along this pathway of T-cell di!erentiation,
from insu"cient Tcr rearrangements to underrepresentation of
any of the T cell lineages, can lead to impaired immune function
(29, 30).
Single-cell RNA sequencing, for example Drop-Seq (31), In-
Drop, or the commercial 10X Genomics and Dolomite platforms
allow the analysis of the transcriptomes of thousands of single-
cells (32). These analyses have been invaluable for identifying
immune-cell subtypes within populations traditionally classified
by discrete cell surface markers (33) and revealed new regulatory
pathways (34).
Here, we used a previously established murine model of FGR
in order to assess the e!ect of an adverse in utero environment
on neonatal and adult immunity. The Igf-2P0 (P0) transcript is
imprinted and paternally expressed leading to specific loss of
placental Igf2 and growth restriction in the fetuses carrying a P0
transcript deletion (16). We then used Drop-Seq to profile the
transcriptomes of 7,264 cells from neonatal thymi in order to
characterize possible immune perturbations at a cellular level.
METHODS
Mouse Tissue Preparation
Mice were maintained at Central Biomedical Services in
accordance with the UK Home O"ce, Animals (Scientific
Procedures) Act 1986 which mandates ethical review. C57BL/6
dams were mated with Igf-2P0 heterozygous males. Mice
were genotyped as previously described (16). For neonatal
analysis, mice were weighed 5 days after birth prior to organ
collection. For adult mice, body and organ weights were assessed
at 8 weeks of age. Spleens were digested with collagenase D
(11088866001, Sigma, Gillingham, UK) at 1mg/ml in HBSS
(24020091, ThermoFisher, Paisley, UK) for 30min at 37"C and
washed with PBS (D8537, Sigma). Single cell thymic suspensions
were prepared by maceration of the thymi through a 40µm
strainer. Red blood cell lysis was performed with PharmLyse
(555899, BD Biosciences, Wokingham, UK) for 3min at RT
for both spleens and thymi. Resultant suspensions were passed
through a 40µm strainer and live cells counted using trypan blue
(T8154-20ML, Sigma).
Flow Cytometry
Isolated cells were incubated with antibodies listed in Table S1
on ice for 30min in PBS prior to washing. Cell types were
identified as in Table S2. Samples were processed on a BD LSR
Fortessa and the data was analyzed using FlowJo 10. Neonatal
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FIGURE 1 | FGR leads to Brain-Sparing at the Expense of Thymus. WT dams were mated with P0 males to produce P0 and WT offspring. The number of WT and P0
animals or organs analyzed for each measurement is given in parentheses. (A) Neonates were analyzed 5 days after birth for absolute body weight (n = 61, 19).
Relative body and organ weights from P0 neonates were compared with littermate controls. Purple dashed line was defined by the average P0 body weight, to allow
relative comparison of organ weights to both P0 and WT. (Relative Body Weight n = 41, 18; Brain n = 7, 5; Spleen n = 32, 11; Thymus n = 28, 12). Organ/Body
ratios were compared between P0 and WT littermates. (B) Absolute cell counts within the spleen and thymus were compared with littermate controls (Spleen Cells n
= 16, 8; Thymus Cells n = 7, 5). Cell counts as a ratio to mouse weights were compared with littermate controls. (C) Spleen cells were analyzed using flow cytometry
and the proportions of the indicated immune cell populations were compared with littermate controls (Spleen Flow Cytometry n = 10, 5, with 1 outlier removed using
the ROUT method). Datasets were tested for normality using the Shapiro-Wilk normality test. Normally distributed data were compared using unpaired two-tailed
t-tests while non-parametric data were compared using Mann-Whitney Rank comparison tests. For all tests, *P < 0.05.
and adult samples were analyzed using the same gating strategy
(Figures S1–S3).
Statistical Analysis
For fold change calculations, Igf-2P0 mice were compared to
litter mate controls with each metric being divided by the mean
value obtained from WT litter mates. Outliers were identified
within each data-set using the ROUTmethod in GraphPad Prism
where Q = 1. This identified only one outlier (Splenic immune
subsets, Figure 1, P0) which was subsequently removed. Datasets
were tested for normality using the Shapiro-Wilk normality test.
Normally distributed data were compared using unpaired two-
tailed Student’s t-test while non-parametric data were compared
using the Mann-Whitney Rank comparison test. Cell cycle data
was analyzed using a two-way ANOVA with Tukey’s multiple
comparisons test across cell types or multiple t-tests using Two-
stage step-up method of Benjamini, Krieger, and Yekutiele across
genotypes.
Drop-Seq
Thymi were dissected from postnatal day (PND) 6 neonates
and homogenized in PBS before passing through a 40µm filter.
Cells were counted and diluted to 200,000 cells/mL in PBS/0.1%
BSA (A7906-100G, Sigma) for processing according to Drop-
Seq protocol (31). Single cells were encapsulated in droplets
with primer barcoded beads (MACOSKO-2011-10, ChemGenes,
Wilmington, USA). After RNA binding to the oligo-dT portion
of the primer, the droplets were broken to pool beads for reverse
transcription (EP0743, ThermoFisher). Exonuclease (EN0581,
ThermoFisher) treatment removed unused primers from the
beads prior to PCR amplification at up to 8,000 beads/tube (!400
cells/tube). Samples were pooled with up to 4,000 cells/sample
and the DNA purified before determining concentration. DNA
was fragmented and tagged with Illumina adapter and index
sequences using Nextera Sequencing kit (FC-131-109, Illumina,
Little Chesterford, UK) and 600 pg DNA/sample. Samples were
diluted 1:1 in ddH20 water before double-sided purification
with Agencourt Ampure beads (A63881, Beckman Coulter, High
Wycombe, UK), using 0.6# beads to remove large fragments and
1# beads twice to remove contaminating primers. Samples were
analyzed for size distribution using an Agilent HSDNA kit (5067-
4626, Agilent, Stockport UK) and concentration and sequenced
on an Illumina HiSeq4000 with an Index read of 8bp, Read 1 of
25 bp and Read 2 of 100 bp. Samples were collected from two
separate litters (two WT and one or two P0 animals per litter).
Single-cell barcoded cDNA was generated for each sample with
littermates being processed on the same day. Library preparation
was done for all samples on the same day using Nextera indices
to distinguish between each neonate. All samples were sequenced
together in one lane of an Illumina HiSeq4000 flow cell.
Bioinformatic Analysis
All custom code is freely available on GitHub (https://github.
com/darogan/2018_Bacon_Charnock-Jones). Raw Fastq
files are demultiplexed (dropseq_demultiplex.sh) using
the Nextera indices and then converted to uBAM using
PicardTools:FastqToSam (v2.9.0). Quality control, alignment
(STAR v020201) gene quantification and final matrix generation
were performed using DropSeqTools (v1.12, http://mccarrolllab.
com/dropseq). Alignments were performed against the mouse
reference genome (mm10 available from http://mccarrolllab.
com/dropseq). Initial thresholds of a minimum 200 genes
per cell and genes must be present in at least 3 cells were
applied. The resulting digital expression matrix (DEM) was
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FIGURE 2 | Single Thymic Cell Transcriptomics reveal T-Cell Differentiation Pathway. (A) Drop-Seq of 7,264 single-cells from WT and P0 thymi were mapped using
non-linear dimensional reduction [t-Distributed Stochastic Neighbor Embedding (tSNE)] using WT signatures derived from linear dimensionality reduction (Principal
Component Analysis, PCA), with signal from known cell cycle genes regressed. Cells separated into eight clusters, denoted by color, and number. Known marker
genes were used to identify each cluster. (B) Marker transcript levels across cells. Purple indicates detected transcripts. (C) Marker transcript levels within each
cluster. Average Expression Normalized refers to the amount of transcripts discovered while Percentage Expression denotes the proportion of cells within a given
cluster containing the transcript. (D) Consistency of sub clustering was assessed at three levels of resolution. (E) Overall, these markers yielded a differentiation map
from DN in Cluster 1 through to mature T cells in Cluster 6. RBC: Red blood cell.
imported into Seurat (35) (v2.3.0) for downstream analysis and
is split into two scripts. The first, dropseq_seurat_splitDEMs.R,
performs the more computationally intensive tasks intended
to be run on high performance computers, the Seurat object
is saved in Robj format to be imported in to second script,
dropseq_seurat_splitDEMs_Plots.R, for di!erential transcript
analysis and figure creation.
Two separate DEMs were calculated for the WT and WT+P0
samples. The WT only samples were used to calculate variable
genes (FindVariableGenes), which were then used as input to
generate the PCA (RunPCA), find clusters (FindClusters) and
produce a tSNE (t-distributed stochastic neighbor embedding)
visualization (RunTSNE) from the combined WT and P0 sample
DEM. FindClusters is run across multiple resolutions (0.2, 0.4,
0.6, 0.8, and 1.0), each stored on the Seurat Object. Normalization
(NormalizeData), UMI and MT regression (FilterCells) were
performed using Seurat including a more stringent threshold of a
minimum 300 genes per cell and genes must be present in at least
3 cells was applied. Cell cycle assignments were performed using
SCRAN (36) (v1.6.9) on the combined WT+P0 DEM, using an
intermediate SingleCellExperiment (v1.0.0) data structure, and
then added back to the Seurat Object. Cell cycle genes were
regressed out using a subtraction of G2M from S cell cycle scores
per cell. The resulting Seurat data object is saved as an RObj
for input into the plotting and di!erential analysis part of the
pipeline.
The RObj generated from first dropseq_seurat_splitDEMs.R
script are imported into dropseq_seurat_splitDEMs_Plots.R to
extract (e.g., with GetCellEmbeddings) the required data for
each of the plots in the figures. Custom tSNE plots were
generated using ggplot2. Transcript abundance dotplots were
generated from AverageExpression extracted from the Seurat
object and ggplot2. Cluster trees were generated using clustree
(37). Di!erential transcript analysis was performed by comparing
each cluster in turn to all others (FindAllMarkers) and using a log
fold change threshold of > 0.7 and adjusted p-value < 0.01. The
heatmap (pHeatmap), used the same thresholds, and the top 20
genes for each cluster selected.
A custom tool was created to classify whether ribosomal
proteins are localized on the surface or are internal to
the ribosome structure (https://github.com/darogan/Ribosomal-
Protein). The bioinformatics tool scores each ribosomal subunit
by its distance from the subunit core. We used this to identify
the subunits present on the surface of the ribosome. The tool also
provides features to display and color the subunits in Pymol, and
was used to confirm they are accessible on the surface. A further
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FIGURE 3 | Unsupervised Clustering Driven by T-Cell, Cell Cycle, and Ribosomal Genes. Transcript levels of each cluster were compared with the remaining overall
cell population. The top 20 genes with an absolute fold change above 5 and an adjusted p-value < 0.01 for each cluster were visualized in a heat map and ordered by
genotype (WT vs. P0) followed by cell cycle score (G1, G2/M, or S). The top 20 genes for each of the six clusters results 120 genes, reduced to 72 unique entries.
Each column represents one cell. Signal intensities are shown on a log2 scale. The complete gene lists are provided in Dataset S1.
feature links the gene names for the subunits to the nomenclature
used in the structure file.
Raw sequencing data have been deposited in the ArrayExpress




Placental Insufficiency Leads to Brain
Sparing at Expense of Thymus
When crossing wildtype (WT) C57BL/6 females with
heterozygous mutant Igf2 P0 males, both WT and P0 o!spring
develop in the WT mother. The P0 neonates exhibit poor
placental and fetal growth. Animals were assessed 5 days after
birth for body and immune organ weights, with littermates
used to determine fold changes (Figure 1A). This time-point
was chosen as it is early within the murine neonatal period
but provided su"cient tissue. Consistent with previous data
(16), the overall body weight was reduced while brain weight
was only marginally a!ected. Spleens of FGR P0 neonates
were smaller than WT but this change was proportionate
to body weight. However, overall cell number was reduced
(Figure 1B). Further investigation using flow cytometry
revealed a number of perturbed lineages, where neutrophils
and macrophages were the most a!ected by FGR (Figure 1C).
The thymus su!ered markedly more growth restriction than
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FIGURE 4 | T-cell maturation and cell cycle stage are linked. (A) Individual
cells were scored for their cell cycle genes (G1, S and G2/M, as described in
Methods). (B) The proportions of these cells within each cell population were
compared using student t-tests (DN, Cluster 1; DP, Clusters 2-5; TMat, Cluster
6). (C) The proportion of WT and P0 cells in each phase were compared. (*P <
0.05; n = 7).
the spleen with disproportionately reduced size and a nearly
70% reduction in cells compared to littermate controls. Given
the overall severity in thymocyte reduction, we used Drop-Seq
to investigate the e!ects of FGR at the single-T-cell level.
Within the Igf-2 locus, neither WT nor P0 thymocytes cells
contained reads aligned to the P0-specific upstream exon U2
(Figure S4), confirming that placental-specific P0 was not
expressed in T cells. This suggests, therefore, that the observed
phenotype was a not result of a direct e!ect of loss of local
Igf-2 but rather, insu"cient placental supply of nutrients.
The Igf2 locus contains a number of transcript variants from
the placental P0 through to P4 (38). We also examined reads
mapping to the other isoforms and did not notice any distinct
patterns except that in the P0 mutant there were a number




To investigate the e!ect of FGR on T-cell development, we
performed Drop-Seq analysis of 4,679 WT and 2,585 P0 thymic
cells (n = 4 and 3 animals respectively) with an average
read depth of 32,399 reads/cell resulting in an average of 994
transcripts per cell (sequencing statistics are in Table S1). We
performed a post-hoc power estimate based on our sequencing
metrics (39). Our 7,264 cells have a mean reads (per gene per
cell) of 5.8 which is well in excess of the minimum threshold of
0.02. This also holds for the WT (6.6) and P0 (4.0) experiments if
considered separately.
The transcript signatures of each WT cell were used to
identify clusters and the genes driving that clustering. We
regressed out the signals from cell cycle regulator genes when
determining the cluster map, which they otherwise a!ected due
to the intrinsic link between cell cycle and T-cell di!erentiation
(40) (Figure S5). Using the remaining cluster determinants, we
mapped both WT and P0 cells into 8 clusters of 7,264 single cells
(Figure 2A). Initially, we used known di!erentiation markers to
define these clusters (Figures 2B,C). We identified the known
T-cell maturation pathway, beginning with cells containing
high levels of Il2ra (Double Negative, DN) through to Cd4/8
containing cells (Double Positive, DP) and ending with high
levels of Ccr7 and Itm2a (TMature). In this map dominated by
DP cells, we were unfortunately not able to distinguish CD4
and CD8 single positive mature T cells. Bias in identifying
clusters was checked using various degrees of resolution, from
0 (identifying only 1 cluster) to 1 (identifying 11; Figure 2D and
Figure S6). This shows distinct DN1 separation even at the lowest
resolution but heterogeneous DP subclustering. Regardless of
resolution, cells clustered into distinct T-cell populations based
upon di!erentiation status (Figure 2E). Of note, we found that
the DP cells were highly heterogeneous and could be divided
into multiple clusters, suggesting that the traditional definition
using two markers is insu"cient to fully characterize these cells.
Cells in Cluster 7 were identified as contaminating red blood cells
due to high hemoglobin mRNA levels, while Cluster 8 contained
macrophages, identified by abundant Aif1, Lyz2, Complement,
and H2 complex transcripts. As both of these clusters contained
fewer than 100 cells, we focused our attention on the larger T-cell
clusters.
Drop-Seq Identifies Transcript Signatures
in T-Cell Maturation
To further characterize these cell clusters, we identified the top
marker genes in each cluster by performing a di!erential analysis
of each cluster compared to all others in an unsupervised manner
(adjusted P-value <0.01; Table S2). These genes included both
known T cell specific markers such as Cd8 and Ccr9 and
cytoskeletal components (Figure 3). We prevented cell cycle
genes driving the clustering (by regression), but in the di!erential
expression analysis the unregressed data were used. A number
of cell cycle regulators were found to di!er between mapped
clusters, demonstrating a clear connection between cellular
phenotype and the stage of the cell cycle. Cluster 1, containing
the DN cells, was characterized by early T-cell markers Il2ra
and Hes1. Tcr!-C1, and C2 were also found within these
cells, likely because only DN cells contain precursor T!" cells.
Cluster 2, the early DP cluster, contained T-cell genes Granzyme
A and Ctage5, as well as Ranbp1, Nolc1, and Hspd1, which
are associated with nuclear pore transport, rRNA processing
and protein folding, respectively. Plac8 was also found, which
was previously implicated in T-cell development (41) but here
specifically found within DN cells. Clusters 3 to 5, which we have
identified as increasingly mature DP cells, contained high levels
of Tarpp (also known as Arpp21), Rag1 and Rag2, whose proteins
are present during TCR rearrangements. During T-cell positive
selection, Tarpp levels are reduced (42), which is shown here as
the TMat cluster contains few Tarpp transcripts. These cells also
showed increasing levels of Ccr9, the CCL25 receptor expressed
on late DN and DP T cells. These known T-cell markers were
found alongside Btg2, a cell cycle inhibitor, and Rmnd5a, which
is necessary for mitotic division. Clusters 2 & 3 both contained
Rrm2, Tyms, and Esco2, which synthesize nucleotides and bind
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FIGURE 5 | Ribosomal protein transcripts distinguish T-cell maturation steps. (A) Significant changes (p < 0.01; log10 Fold Change > 0.7) in ribosomal protein
transcripts within Cluster 3 and Cluster 4 were compared. Ribosomal genes in bold code for proteins found on the surface of the ribosome. (B) Ribosomal protein
transcript levels are displayed across cells using average expression values for the 13 genes identified by comparing Clusters 3 and 4. (C) Ribosomal genes identified
to be localized on the surface of the ribosome are mapped onto the ribosome structure (red, PDB:6EK0). Supplemental Movie 1 visualizes the surface ribosome
genes identified on the structure as it rotates on the y-axis.
sister chromatids, respectively, and are required for S phase of the
cell cycle. The variations of Clusters 2 through 5 then are likely
in part due to progressive rounds of proliferation as the T cells
mature.
The mature lymphocyte markers Itm2a and Cd52 are specific
to Cluster 6, alongside a number of cytoskeletal (Cd2, Tmsb4x,
andTmsb10). Negative growth regulators Slfn2,Gimap4,Ms4a4b,
and Shisa5 are also present in high levels in the TMat cluster, likely
involved with positive and/or negative selection. Interestingly,
the DN Cluster 1, DP Cluster 4, and TMat Cluster 6 contained
heterogeneous mixtures of cells with high and low levels of
transcripts coding for ribosomal proteins.
Cell Cycle and Ribosomal Protein
Structure Drive Thymocyte Maturation
We further investigated the trends in cell cycle and ribosomal
protein genes. Although we prevented known cell cycle genes
from determining the cluster map, we did not remove these
genes from the transcript profile of each cell. When comparing
transcript signatures between clusters, we detected di!erences
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FIGURE 6 | FGR Leads to T-Cell Differentiation Delay. (A) Single-cell map colored by genotype with previous cluster numbering. Red: P0, 2,585 cells, n = 3. Teal: WT,
4,679 cells, (n = 4). (B) Visual representation of the proportions of cells in each genotype per cluster, averaged from each trial and labeled for each cluster. Clusters
are labeled by number, from the DN T-cell stage in Cluster 1 to TMat in Cluster 7. P0 is in the inner circle, while WT is in the outer circle. (C) Proportions of cells within
each cell population as determined by Drop-Seq were compared to WT levels. (D) Cells were classified by their surface markers using flow cytometry as DN, DP,
CD4+, or CD8+ cells and proportions were compared with littermate controls (n = 9, 5). Within the DN population, cells were classified from DN1 to DN4 based on
their CD25 and CD44 status. These proportions were then compared with littermate controls. Comparisons were calculated using Student’s t-test with the exception
of the Cluster 5 (C), DN, and DN3 (D) subsets, which failed to pass the Shapiro-Wilk test for normality and were instead analyzed using Mann-Whitney Rank
comparison tests (*P < 0.05).
in cell cycle stage, likely due to a link between cell type and
proliferation state (see Figure S5 for cluster mapping with and
without cell cycle regression). We scored each cell for its G1, S,
or G2/M phase transcript signature (Figure 4A) and compared
cycle phase between cell types (Figure 4B). DN and TMat stages
had lower levels of proliferation than the DP stage. There were
no di!erences in cell cycle overall between WT and P0 genotypes
(Figure 4C).
A di!erential transcript analysis for each cluster against all
others revealed that within the DP stage, ribosomal protein
transcripts were varied, most notably between Clusters 3 and
4. We made the same observation of a di!erential ribosomal
protein transcript population in the unsupervised clustering
in Figure 3. The ribosomal protein mRNAs that significantly
changed in Cluster 3 were compared against those found in
Cluster 4 (Figure 5A). In each case, cells in Cluster 3 were
notable for low ribosomal protein transcript abundance while in
Cluster 4 such transcripts were increased. The majority of the
transcripts (9 out of 13, 69%) found by this comparison between
clusters coded for proteins that contributed to the ribosome
surface. Surface proteins are more likely to play a functional or
regulatory role than internal proteins. The protein subunits of a
ribosome are known to play a key role in directing translation
of specific mRNA pools (43). Looking at the overall cluster
mapping, we found that the ribosomal transcripts appeared in
waves dominating Cluster 4 and dividing Cluster 6 (Figures 5B,C
Movie S1).
FGR Prevents Thymocyte Maturation
Having identified each cluster and compared the top gene
signatures, we then compared the WT and P0 thymocytes within
each cluster (Figure 6A). Even after accounting for the higher
number of WT cells present, we still found a higher proportion
of DN cells in the P0 thymus than WT (Figures 6B,C). The
opposite held true with the late stage TMat cluster, as there
were proportionally more TMat cells in the WT thymus than
the P0. Overall, there was a general skew of P0 cells toward
earlier, more immature clusters in the DP pathway, while
the WT thymus favored the later stage clusters. Using flow
cytometry for surface markers, we detected discrete increases
in DN cells at the expense of mature CD4+ cells in the
P0 (Figure 6D). Within the smaller DN cell population, there
were proportionally more DN3 cells in the P0 over the WT,
which is noteworthy given that rearrangement of V and D
chains as well as # selection occur at this stage in T-cell
di!erentiation.
FGR Transcript Signatures
Given the apparent waves of ribosomal transcripts appearing in
Figure 3, we looked more deeply within clusters to determine
whether FGR changed transcript signatures of seemingly
equivalent cell types (Figure 7, Supplemental Tables 7A–E). We
first identified genes that distinguished major cell type (DN vs.
DP or DP vs. TMat, Figures 7A,B, individual cluster comparisons
in Figure S7, Supplemental Tables 7A1–15). As expected, Cd8
and Cd4 genes dominated for the DP to DN comparison, whilst
Cd52 and Itm2a distinguished TMat fromDP in this unsupervised
comparison. We then looked within clusters for changes
due to FGR (Figures 7C–E, individual cluster comparisons in
Figure S8, Supplemental Tables 8A1–6). Within each cluster,
ribosomal protein transcripts were found at significantly higher
levels in the WT over the P0. Xist was also found, which
indicates the presence of a female in the P0 group (Figure S9
shows the consistent overlap of the female P0 with the male
P0 neonatal T-cells indicating that sex has little e!ect on these
cells). Interestingly, Igf2 was present in lower levels in the
WT DN and TMat clusters, note that this refers to total Igf2
rather than the placental specific isoform. We then investigated
overarching trends across clusters by comparing genes which
di!er between WT and P0 cells, within each cluster to another
cluster (Figures 7F,G). The ribosomal protein transcripts aligned
clearly, demonstrating an overall trend as opposed to a cluster-
specific phenomenon.
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FIGURE 7 | Differential transcript levels between identified cell type clusters and within cluster WT/P0 differences. (A,B) Volcano plots for differential transcript levels
between the DN/DP and DP/TMat cell type clusters. The top 10 genes are labeled for +/– average log fold change. (C–E) Within cluster, WT vs. P0 cell transcript level
comparisons revealing the ribosomal protein genes as the dominant set of genes especially evident within the DP cell type. (F,G) Comparison of the transcript level
fold change between DN/DP and DP/TMat cell type clusters shows a similar enrichment for the ribosomal protein genes (purple).
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FIGURE 8 | Immune cell deficiency persists into adulthood. (A) Absolute weights of 8 week male P0 and WT were compared (n = 7, 6). Body (n = 7, 4), spleen (n =
7, 4), and thymus (n = 5, 3) weights were compared with littermate controls. Spleen/body and thymus/body weight ratios were also compared relative to littermate
controls to account for lower overall body weight in the P0 mice. (B) Total cells within the spleen (n = 4, 4) and thymus (n = 5, 3) were compared directly with
littermate controls as well as relative to overall mouse weight. (C) Surface markers were used to classify T cells within the thymus and the proportions were compared
to littermate controls (n = 8, 7). (D) Splenic immune subset proportions were determined from flow cytometry and compared with littermate controls (n = 5, 7).
Datasets were tested for normality using the Shapiro-Wilk normality test. Normal data were compared using unpaired two-tailed t-tests while nonparametric data were
compared using Mann-Whitney Rank comparison tests. For all tests, *P < 0.05.
Immune Defect Lasts into Adulthood
Thymus size is correlated with thymus function (44). Humans
with DiGeorge syndrome have little or no thymus, resulting in
a significant immunodeficiency (45, 46). We wondered whether
the maturation delay in the thymus of the 6-day old neonate
would a!ect the immune cell population in the adult. Infants
with FGR exhibit increased growth and “catch up” relative to
their unrestricted counterparts (47). Adult male mice displayed
signs of catch-up growth, although they were still found to be
significantly lighter than their littermate controls (Figure 8A).
However, the spleen and thymus weights were not di!erent from
littermate controls. Despite this, the cellularity of the thymus was
still significantly reduced (58% ± 19%, P = 0.019, Figure 8B).
However, as both DN and CD4+ lineages recovered to WT
proportions the long-term e!ects of poor placentation on cell
distributions in the adult thymus are less clear (Figure 8C).While
we did not evaluate the repertoire diversity or clonality, we did
observe that DN subtypes were statistically distinct from WT
(Figure 8D).
DISCUSSION
We present the first single-cell analysis of the neonatal
thymus, in the context of a disease model for FGR. Recently,
interest in fetal immunity has led to the generation of a
cell atlas for the developing thymus (48). Here, we add
to this atlas with an insight into thymic development after
birth. We found a number of genes in common with
these early developmental snapshots, such as H19 and Plac8,
but were further able to resolve multiple developing T-cell
populations due to the seemingly increased thymic activity after
birth.
The “fetal programming of adult disease” theory has largely
been associated with non-communicable diseases such as obesity
or heart disease. Within this wider context, we present the first
genetic model suggesting that an adverse in utero environment
perturbs immune cell development. This may lead to poor
immune function later in life and consequently a higher risk of
communicable diseases.
Our study has identified a novel sequela of FGR in the
mouse: a lasting deficit in T cells, resulting from a maturation
delay found in the growth restricted neonate. At the cellular
level, there were more DN cells and a skew toward early DP
cells. The high heterogeneity of DP cells found here suggests
that current definitions of DP are not specific enough given
the large proportion of the thymic T cells in this category.
Our 26 supplemental tables from the single-cell dataset provide
numerous candidates for future investigation of subcluster
markers and some of these may be functionally relevant to the
di!erentiation process. Of particular note is the high number
of ribosomal protein transcripts driving clustering within this
group. Ribosome biogenesis has recently been shown to play
a key role in stem cell di!erentiation (49) and translation of
specific pools of mRNAs depends on the ribosomal protein
composition (43). This is particularly noticeable with defects
in specific ribosomal protein genes, which can lead to discrete
e!ects such as an erythropoiesis block in hematopoietic stem
cells (50) or a loss of body hair (51), as opposed to an expected
generalized protein deficit. Clusters 1, 4, and 6–comprised of
DN, late DP and maturing T cells—seem to subcluster based
on ribosomal protein transcript levels. The ribosomal proteins
encoded by these transcripts, located largely on the outside of
the ribosome, are greatly reduced in the P0 mice. It is interesting
to speculate that within this T-cell di!erentiation pathway,
ribosome biogenesis, and hence function, plays a role in directing
maturation.
The clusters were defined by transcript signatures after
excluding cell cycle regulators. Nevertheless, distinct cell cycle
signatures were present within the clusters, confirming that
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proliferation and T-cell maturation are inexorably linked, which
is consistent with a similar finding in specifically CD4+ T-cell
di!erentiation (40).
How this early phenotype leads to low thymic cellularity in
the adult remains unclear. Infants with FGR typically undergo
“catch-up growth” to reach normal or near normal weight. This
was the case here for all parameters except thymus cellularity.
T-cell maturation, is linked at a molecular level to cell cycling
because RAG2 is degraded during G2, S, and M phases (52).
Perhaps thymic “catch-up growth” and T cell diversification and
maturation are incompatible because proliferation inhibits T-cell
maturation. Indeed, the similar cell-cycle profiles of the P0 and
WT thymic cells is indicative of a lack of catch-up growth in
the P0 thymus. It is also possible that catch-up growth cannot
occur because the thymus is programmed to involute after birth,
rather than expand. In either case, growth restriction early in life
would be irreversible: the number of T-cell clones generated in
the neonatal thymus restricts the number of T-cell clones present
in the adult.
In both mice and humans, thymus output declines with
age, with the memory T cells dominating the peripheral
pool in old age (53). The diversity and clonality of naive
T cell also change with age (54). Immune function declines
with age and there is an increased risk of infection and
malignancy late in life (44). Genetically manipulated mice with
enlarged thymi have increased thymic activity and enhanced
recovery from ! irradiation (55). In contrast, patients with
DiGeorge syndromes where the thymus is small display immune
vulnerability early in life (45, 46). Thus, a thymic deficit
early in life could have dramatic e!ects on adult immunity
which would only become exacerbated by normal thymic
involution.
Overall, we have identified key immune phenotypes
caused by placental insu"ciency. Future studies will
ultimately determine the role of FGR in both neonatal and
adult immunity. Nevertheless, we have shown a distinct
and negative impact of FGR on immune cells in the
mouse.
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